THE RCRF WORKS WITH WORLD-CLASS CANCER FOUNDATION PARTNERS. WE REPRESENT CANCER TYPES FROM GLIOBLASTOMA TO MELANOMA, WORKING TOGETHER FOR CURES.
Angiosarcoma Awareness Inc. is a patient-driven nonprofit dedicated to researching better therapies and a cure for angiosarcoma.
ATCC is the premier global biological materials resource and standards organization whose mission focuses on the acquisition, authentication, production, preservation, development, and distribution of standard reference microorganisms, cell lines, and other materials. While maintaining traditional collection materials, ATCC develops high quality products, standards, and services to support scientific research and breakthroughs that improve the health of global populations.
ABC2 breaks through the boundaries of academia, nonprofits, industries and other research fields to find the cure for brain cancer.
The Adenoid Cystic Carcinoma Research Foundation (ACCRF) supports research into adenoid cystic carcinoma that will accelerate the development of improved therapies and a cure for the disease.
The Bili Project is a Hepatobiliary Cancer Awareness and Research Program. It’s mission is to reduce the incidence and improve the outcomes of Hepatobiliary cancers by promoting research to identify biomarkers and therapeutic targets.
CAC2 effectively advances a variety of childhood cancer causes by unifying the childhood cancer community through broad-based coordinated action and collaboration that leverages the strengths and expertise of its individual members and minimizes duplication of effort.
The mission of the Cholangiocarcinoma Foundation is to find a cure and improve the quality of life for those affected by cholangiocarcinoma. The logo of the Cholangiocarcinoma Foundation represents the biliary system which looks similar to a tree.
The Chordoma Foundation is a nonprofit organization working to improve the lives of chordoma patients by accelerating research to develop effective treatments for chordoma,and by helping patients to get the best care possible. The organization is renowned globally for its leadership in finding new ways to fund and facilitate rare cancer research
.
Founded in 2005, the Desmoid Tumor Research Foundation (DTRF) is dedicated to funding research for a cure for desmoid tumors.
The mission of the Dragon Master Foundation is to develop and implement tools and technology to empower brain cancer researchers to collaborate more effectively, and further, to encourage that collaboration to find a path to the cure.
The Fibrolamellar Cancer Foundation’s (FCF) mission is to find a cure and treatment options, raise awareness and connect and support the fibrolamellar community of patients and their families.
The HPV and Anal Cancer Foundation is dedicated to empowering anal cancer patients and accelerating prevention and research methods that eliminate anal cancer and the virus that causes the majority of cases, HPV.
The MPN Research Foundation has a single goal: to stimulate original research in pursuit of new treatments — and eventually a cure — for the rare blood cancers polycythemia vera, essential thrombocythemia and myelofibrosis, known collectively as myeloproliferative neoplasms (MPN).
The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for carcinoid, pancreatic, and related neuroendocrine cancers.
The National Leiomyosarcoma Foundation is committed to LMS patient-family/caregiver education and support, patient advocacy, research funding and organizational collaborative partnerships in order to support the LMS community and advance treatment breakthroughs.
The mission of the Ocular Melanoma Foundation (OMF) is to accelerate and enhance scientific research, advocacy, and awareness of ocular melanoma and to provide education and support to patients, their families, and healthcare professionals.
TargetCancer Foundation promotes the development of lifesaving treatment protocols for rare cancers. TargetCancer Foundation directly supports initiatives at the forefront of cancer treatment by funding innovative research, fostering collaborations, and raising awareness among scientists, clinicians, and patients.